Last reviewed · How we verify
NCT07091474: Little-Movers
Promoting Motor Development in Infants and Toddlers Through Education and Early Detection
trial testing Educational Workshops for Parents and Early Educators in Typical Development in 80 participants. Not yet recruiting.
1 April 2027
Quick facts
| Lead sponsor | University of Castilla-La Mancha |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 80 |
| Start date | 1 September 2025 |
| Primary completion | 1 April 2027 |
| Estimated completion | 1 September 2027 |
Drugs / interventions tested
- Educational Workshops for Parents and Early Educators
- Motor Development Assessment in Children 0-36 Months
Conditions studied
- Typical Development — all drugs for Typical Development →
Sponsor
University of Castilla-La Mancha
Who can join
Adults 0 Months to 36 Months, any sex, with Typical Development. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The "Little Movers" study promotes healthy motor development in early childhood by providing education to caregivers and professionals in the child's environment and by implementing early detection strategies for motor delays. The primary prevention component includes structured educational workshops designed for three age groups: 0-12 months, 13-24 months, and 25-36 months. These workshops focus on typical motor milestones, the importance of active play, early stimulation strategies, and how to recognize early warning signs of motor development delays. Participation impact will be measured using pre- and post-workshop surveys and semi-structured interviews with parents, caregivers, and educators. The secondary and tertiary prevention component consists of a longitudinal observational study that follows infants aged 0 to 12 months. Motor development will be assessed using validated tools, including the Standardized Infant Hand Assessment (s-HAI), the Hammersmith Infant Neurological Examination (HINE), the Infant Motor Profile (IMP), and the Ages and Stages Questionnaire (ASQ-3). Infants with typical development will be reassessed annually, while those at risk or showing signs of motor delay will be monitored monthly. The goal is to detect motor delays as early as possible to allow timely referral and intervention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07091474
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Typical Development
Currently open trials in the same condition.
- NCT06764810 — Association Between Motor Skills and Sensory Profiles in Children With Typical and Atypical Development Aged 4 to 11 Yea · recruiting
- NCT04631042 — Developing Brain, Impulsivity and Compulsivity · recruiting
Other University of Castilla-La Mancha trials
Trials by the same sponsor.
- NCT07487857 — Intensive Somatosensory Camp for Manual Function and Participation in Children With Unilateral Cerebral Palsy · NA · not yet recruiting
- NCT07419035 — Bipolar Radiofrequency for Genitourinary Syndrome of Menopause · NA · not yet recruiting
- NCT07452172 — Lumbar and Gluteal Motor Control in Chronic Low Back Pain · NA · not yet recruiting
- NCT07041944 — HEMImprove 1.0 in Children and Adolescents With Unilateral Cerebral Palsy · NA · not yet recruiting
- NCT07091461 — HOMe-IMprove Telerrehabilitation System · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07091474 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Castilla-La Mancha
- Last refreshed: 29 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07091474.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing